Stuart Smith, DO
Internal Medicine · Warrensburg, MONPI 1659375525
Payments from drug & device makers
Across 172 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$344
- AstraZeneca$246
- Johnson & Johnson$240
- Lilly USA, LLC$182
- Boehringer Ingelheim$176
- Novo Nordisk$163
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,422100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 30 | $344 |
| AstraZeneca | 15 | $246 |
| Johnson & Johnson | 17 | $240 |
| Lilly USA, LLC | 13 | $182 |
| Boehringer Ingelheim | 11 | $176 |
| Novo Nordisk | 12 | $163 |
| Merck | 11 | $152 |
| AbbVie(2 entities) | 8 | $118 |
| Amgen | 7 | $103 |
| Amarin Pharma, Inc. | 6 | $87 |
| Collegium Pharmaceutical, Inc. | 6 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $80 |
| Astellas Pharma US Inc | 5 | $74 |
| Sunovion Pharmaceuticals Inc. | 3 | $51 |
| Novartis | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Mylan Specialty L.p. | 3 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Abbott | 2 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
How this compares
$2,422 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Warrensburg
- Syed HasanWarrensburg$17K
- Timothy SmithSaint Peters$21.4M
- Craig DietzKansas City$4M
- Michael ReschakSaint Louis$3.1M
- Dima DandachiColumbia$1.2M
- Santosh SharmaKansas City$782K
- Jianbo WangChesterfield$643K
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
- Dubert GuerreroIndependence$369K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.